Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kanduri Meena) "

Sökning: WFRF:(Kanduri Meena)

  • Resultat 1-10 av 72
  • [1]234567...8Nästa
Sortera/gruppera träfflistan
  • Kanduri, Meena, 1974-, et al. (författare)
  • A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
  • 2013
  • Ingår i: Epigenetics. - 1559-2294 .- 1559-2308. ; 8:12, s. 1280-8
  • Tidskriftsartikel (refereegranskat)abstract
    • The chromatin modifier EZH2 is overexpressed and associated with inferior outcome in mantle cell lymphoma (MCL). Recently, we demonstrated preferential DNA methylation of HOX genes in MCL compared with chronic lymphocytic leukemia (CLL), despite these genes not being expressed in either entity. Since EZH2 has been shown to regulate HOX gene expression, to gain further insight into its possible role in differential silencing of HOX genes in MCL vs. CLL, we performed detailed epigenetic characterization using representative cell lines and primary samples. We observed significant overexpression of EZH2 in MCL vs. CLL. Chromatin immune precipitation (ChIP) assays revealed that EZH2 catalyzed repressive H3 lysine 27 trimethylation (H3K27me3), which was sufficient to silence HOX genes in CLL, whereas in MCL H3K27me3 is accompanied by DNA methylation for a more stable repression. More importantly, hypermethylation of the HOX genes in MCL resulted from EZH2 overexpression and subsequent recruitment of the DNA methylation machinery onto HOX gene promoters. The importance of EZH2 upregulation in this process was further underscored by siRNA transfection and EZH2 inhibitor experiments. Altogether, these observations implicate EZH2 in the long-term silencing of HOX genes in MCL, and allude to its potential as a therapeutic target with clinical impact.
  • Kosalai, Subazini Thankaswamy, 1980-, et al. (författare)
  • EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
  • 2019
  • Ingår i: Epigenetics. - 1559-2294. ; 14:11, s. 1125-1140
  • Tidskriftsartikel (refereegranskat)abstract
    • EZH2 is overexpressed in poor-prognostic chronic lymphocytic leukaemia (CLL) cases, acting as an oncogene; however, thus far, the EZH2 target genes in CLL have not been disclosed. In this study, using ChIP-sequencing, we identified EZH2 and H3K27me3 target genes in two prognostic subgroups of CLL with distinct prognosis and outcome, i.e., cases with unmutated (U-CLL, n = 6) or mutated IGHV genes (M-CLL, n = 6). While the majority of oncogenic pathways were equally enriched for EZH2 target genes in both prognostic subgroups, PI3K pathway genes were differentially bound by EZH2 in U-CLL versus M-CLL. The occupancy of EZH2 for selected PI3K pathway target genes was validated in additional CLL samples (n = 16) and CLL cell lines using siRNA-mediated EZH2 downregulation and ChIP assays. Intriguingly, we found that EZH2 directly binds to the IGF1R promoter along with MYC and upregulates IGF1R expression in U-CLL, leading to downstream PI3K activation. By investigating an independent CLL cohort (n = 96), a positive correlation was observed between EZH2 and IGF1R expression with higher levels in U-CLL compared to M-CLL. Accordingly, siRNA-mediated downregulation of either EZH2, MYC or IGF1R and treatment with EZH2 and MYC pharmacological inhibitors in the HG3 CLL cell line induced a significant reduction in PI3K pathway activation. In conclusion, we characterize for the first time EZH2 target genes in CLL revealing a hitherto unknown implication of EZH2 in modulating the PI3K pathway in a non-canonical, PRC2-independent way, with potential therapeutic implications considering that PI3K inhibitors are effective therapeutic agents for CLL.
  • Mondal, Tanmoy, et al. (författare)
  • Sense-antisense lncRNA pair encoded by locus 6p22.3 determines neuroblastoma susceptibility via the USP36-CHD7-SOX9 regulatory axis
  • 2018
  • Ingår i: Cancer Cell. - 1535-6108. ; 33:3, s. 417-434.e7
  • Tidskriftsartikel (refereegranskat)abstract
    • Trait-associated loci often map to genomic regions encoding long noncoding RNAs (lncRNAs), but the role of these lncRNAs in disease etiology is largely unexplored. We show that a pair of sense/antisense lncRNA (6p22lncRNAs) encoded by CASC15 and NBAT1 located at the neuroblastoma (NB) risk-associated 6p22.3 locus are tumor suppressors and show reduced expression in high-risk NBs. Loss of functional synergy between 6p22lncRNAs results in an undifferentiated state that is maintained by a gene-regulatory network, including SOX9 located on 17q, a region frequently gained in NB. 6p22lncRNAs regulate SOX9 expression by controlling CHD7 stability via modulating the cellular localization of USP36, encoded by another 17q gene. This regulatory nexus between 6p22.3 and 17q regions may lead to potential NB treatment strategies. Mondal et al. show a sense/antisense lncRNA pair expressed from the neuroblastoma (NB) risk-associated 6p22.3 locus is important for retinoic acid-induced NB differentiation gene-regulatory network by controlling CHD7 stability via modulating the cellular localization of the ubiquitin specific protease USP36.
  • Pandey, Gaurav Kumar, et al. (författare)
  • The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
  • 2014
  • Ingår i: Cancer Cell. - 1535-6108. ; 26:5, s. 722-737
  • Tidskriftsartikel (refereegranskat)abstract
    • Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most common extracranial tumor of childhood. By sequencing transcriptomes of low- and high-risk neuroblastomas, we detected differentially expressed annotated and nonannotated long noncoding RNAs (lncRNAs). We identified a lncRNA neuroblastoma associated transcript-1 (NBAT-1) as a biomarker significantly predicting clinical outcome of neuroblastoma. CpG methylation and a high-risk neuroblastoma associated SNP on chromosome 6p22 functionally contribute to NBAT-1 differential expression. Loss of NBAT-1 increases cellular proliferation and invasion. It controls these processes via epigenetic silencing of target genes. NBAT-1 loss affects neuronal differentiation through activation of the neuronal-specific transcription factor NRSF/REST. Thus, loss of NBAT-1 contributes to aggressive neuroblastoma by increasing proliferation and impairing differentiation of neuronal precursors.
  • Deneberg, Stefan, et al. (författare)
  • microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia
  • 2014
  • Ingår i: Epigenetics. - 1559-2294 .- 1559-2308. ; 9:6, s. 910-917
  • Tidskriftsartikel (refereegranskat)abstract
    • A commonly deleted region in chronic lymphocytic leukemia (CLL) is the 11q22-23 region, which encompasses the ATM gene. Evidence suggests that tumor suppressor genes other than ATM are likely to be involved in CLL with del(11q). A microRNA (miR) cluster including the miR-34b and miR-34c genes is located, among other genes, within the commonly deleted region (CDR) at 11q. Interestingly, these miRs are part of the TP53 network and have been shown to be epigenetically regulated. In this study, we investigated the expression and methylation status of these miRs in a well-characterized cohort of CLL, including cases with/without 11q-deletion. We show that the miR-34b/c promoter was aberrantly hypermethylated in a large proportion of CLL cases (48%, 25/52 cases). miR-34b/c expression correlated inversely to DNA methylation (P = 0.003), and presence of high H3K37me3 further suppressed expression regardless of methylation status. Furthermore, increased miR-34b/c methylation inversely correlated with the presence of 11q-deletion, indicating that methylation and del(11q) independently silence these miRs. Finally, 5-azacytidine and trichostatin A exposure synergistically increased the expression of miR-34b/c in CLL cells, and transfection of miR-34b or miR-34c into HG3 CLL cells significantly increased apoptosis. Altogether, our novel data suggest that miR-34b/c is a candidate tumor suppressor that is epigenetically silenced in CLL.
  • Frank, Stefan, et al. (författare)
  • yylncT Defines a Class of Divergently Transcribed lncRNAs and Safeguards the T-mediated Mesodermal Commitment of Human PSCs.
  • 2019
  • Ingår i: Cell stem cell. - 1875-9777. ; 24:2, s. 318-327.e8
  • Tidskriftsartikel (refereegranskat)abstract
    • Human protein-coding genes are often accompanied by divergently transcribed non-coding RNAs whose functions, especially in cell fate decisions, are poorly understood. Using an hESC-based cardiac differentiation model, we define a class of divergent lncRNAs, termed yin yang lncRNAs (yylncRNAs), that mirror the cell-type-specific expression pattern of their protein-coding counterparts. yylncRNAs are preferentially encoded from the genomic loci of key developmental cell fate regulators. Most yylncRNAs are spliced polyadenylated transcripts showing comparable expression patterns in vivo in mouse and in human embryos. Signifying their developmental function, the key mesoderm specifier BRACHYURY (T) is accompanied by yylncT, which localizes to the active T locus during mesoderm commitment. yylncT binds the de novo DNA methyltransferase DNMT3B, and its transcript is required for activation of the T locus, with yylncT depletion specifically abolishing mesodermal commitment. Collectively, we report a lncRNA-mediated regulatory layer safeguarding embryonic cell fate transitions.
  • Halldorsdottir, Anna Margret, et al. (författare)
  • Mantle cell lymphoma displays a homogenous methylation profile: A comparative analysis with chronic lymphocytic leukemia
  • 2012
  • Ingår i: American Journal of Hematology. - John Wiley and Sons Inc.. - 0361-8609. ; 87:4, s. 361-367
  • Tidskriftsartikel (refereegranskat)abstract
    • Mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) are mature CD5(+) B-cell malignancies with different biological/clinical characteristics. We recently reported an association between different prognostic subgroups of CLL (i.e., IGHV mutated and unmutated) and genomic methylation pattern. However, the relationship between DNA methylation and prognostic markers, such as the proliferation gene expression signature, has not been investigated in MCL. We applied high-resolution methylation microarrays (27,578 CpG sites) to assess the global DNA methylation profiles in 20 MCL (10 each with high/low proliferation signature) and 30 CLL (15 poor-prognostic IGHV unmutated subset #1 and 15 good-prognostic IGHV mutated subset #4) samples. Notably, MCL and each CLL subset displayed distinct genomic methylation profiles. After unsupervised hierarchical clustering, 17/20 MCL cases formed a cluster separate from CLL, while CLL subsets #1 and #4 formed subclusters. Surprisingly, few differentially methylated genes (n = 6) were identified between high vs. low proliferation MCL. In contrast, distinct methylation profiles were demonstrated for MCL and CLL. Importantly, certain functional classes of genes were preferentially methylated in either disease. For instance, developmental genes, in particular homeobox transcription factor genes (e.g., HLXB9, HOXA13), were more highly methylated in MCL, whereas apoptosis-related genes were enriched among targets methylated in CLL (e.g., CYFIP2, NR4A1). Results were validated using pyrosequencing, RQ-PCR and reexpression of specific genes. In summary, the methylation profile of MCL was homogeneous and no correlation with the proliferation signature was observed. Compared to CLL, however, marked differences were discovered such as the preferential methylation of homeobox genes in MCL. Am. J. Hematol., 2012. (C) 2012 Wiley Periodicals, Inc.
  • Holmgren, Claes, et al. (författare)
  • CpG methylation regulates the Igf2/H19 insulator
  • 2001
  • Ingår i: Current Biology. - 0960-9822 .- 1879-0445. ; 11:14, s. 1128-1130
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The differentially methylated 5'-flank of the mouse H19 gene unidirectionally regulates the communication between enhancer elements and gene promoters and presumably represses maternal Igf2 expression in vivo [1-6]. The specific activation of the paternally inherited Igf2 allele has been proposed to involve methylation-mediated inactivation of the H19 insulator function during male germline development [1-4, 6]. Here, we addressed the role of methylation by inserting a methylated fragment of the H19-imprinting control region (ICR) into a nonmethylated episomal H19 minigene construct, followed by the transfection of ligation mixture into Hep3B cells. Individual clones were expanded and analyzed for genotype, methylation status, chromatin conformation, and insulator function. The results show that the methylated status of the H19 ICR could be propagated for several passages without spreading into the episomal vector. Moreover, the nuclease hypersensitive sites, which are typical for the maternally inherited H19 ICR allele [1], were absent on the methylated ICR, underscoring the suggestion that the methylation mark dictates parent of origin-specific chromatin conformations [1] that involve CTCF [2]. Finally, the insulator function was strongly attenuated in stably maintained episomes. Collectively, these results provide the first experimental support that the H19 insulator function is regulated by CpG methylation.</p>
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 72
  • [1]234567...8Nästa
fritt online (4)
Typ av publikation
tidskriftsartikel (64)
annan publikation (5)
konferensbidrag (2)
doktorsavhandling (1)
Typ av innehåll
refereegranskat (65)
övrigt vetenskapligt (12)
Kanduri, Meena, (54)
Rosenquist, Richard (37)
Kanduri, Meena, 1974 ... (17)
Kanduri, Chandrasekh ... (15)
Kanduri, M (13)
Ehrencrona, Hans, (13)
visa fler...
Ohlsson, Rolf (12)
Mansouri, Larry (11)
Rosenquist, R. (11)
Kanduri, Chandrasekh ... (11)
Stamatopoulos, Kosta ... (10)
Juliusson, Gunnar, (10)
Isaksson, Anders, (9)
Abrahamsson, Jonas (8)
Jónsson, Olafur G (8)
Jurlander, Jesper (8)
Zeller, Bernward (7)
Hasle, Henrik (7)
Forestier, Erik (7)
Jahnukainen, Kirsi (7)
Holmgren, Claes (7)
Hovland, Randi (7)
Sander, Birgitta (7)
Thakur, Noopur (7)
Enblad, Gunilla, (6)
Mansouri, L. (6)
Stamatopoulos, K (6)
Palmqvist, Lars (6)
Pfeifer, Susan, (6)
Mukhopadhyay, Ritupa ... (6)
Staffas, Anna (6)
Palle, Josefine (5)
Kanduri, C (5)
Mansouri, Mahmoud, (5)
Subhash, Santhilal, ... (5)
Gunnarsson, Rebeqa (5)
Amini, Rose-Marie (4)
Berglund, Mattias, (4)
Sundström, Christer (4)
Kogner, Per (4)
Cahill, Nicola (4)
Juliusson, G (4)
Roos, Göran, (4)
Sander, B, (4)
Lindell, Monica, (4)
Ehrencrona, H (4)
Kaderi, Mohd Arifin, (4)
Sevov, Marie, (4)
Lonnerholm, Gudmar, (4)
Ntoufa, Stavroula, (4)
visa färre...
Uppsala universitet (41)
Göteborgs universitet (20)
Karolinska Institutet (14)
Lunds universitet (10)
Umeå universitet (4)
Chalmers tekniska högskola (2)
Engelska (63)
Odefinierat språk (3)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (50)
Naturvetenskap (11)
Teknik (2)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy